DEMETRIA MCDUFFEY: Open Payments
NPI 1508550872 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 62 payments from 19 companies in 2025. Trend: 2023 $564 · 2024 $791 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $209 |
| Axsome Therapeutics, Inc. | 7 | $178 |
| Antares Pharma, Inc. | 5 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| PFIZER INC. | 4 | $78 |
| Novo Nordisk Inc | 4 | $77 |
| ViiV Healthcare Company | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Amgen Inc. | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: Auvelity, VRAYLAR, XYOSTED, FANAPT, ELIQUIS, TRELEGY ELLIPTA, QULIPTA, Rybelsus.
Industry payments across MI — which companies pay providers there.
